Norofert Completes 1st Stage Of Project For Construction Of Laboratory For Research And Multiplication Of Microorganisms

The laboratory is located in the premises of the input factory in Filipestii de Padure, owned by the Company, and is the only one of its kind in Romania. 

This first stage of the project marks the completion of the construction of a medium-sized laboratory, representing an advanced and well-equipped technological space, in which the company invested RON3 million. The second stage of the project will start towards the end of 2024, and the total value of the investment will amount to over RON6 million.   An important aspect of this first stage is the close collaboration between the team of researchers and technicians of the Company and the Faculty of Biotechnologies within the University of Agricultural Sciences and Veterinary Medicine (USAMV) Bucharest. Thus, the Company has access to scientific expertise and university resources contributing to the isolation and development of microorganisms owned and registered in its name.   “The laboratory for research and multiplication of microorganisms is equipped with state-of-the-art technology and enables complex research into the processes of multiplication of microorganisms. The research and development of new products represents for Norofert the main growth vector in the medium and long term, the strongest differentiator in a European market where the vast majority of manufacturers do not have a research department in the company. Thus, a key element for the investment in the laboratory is also its international addressability,” said Vlad Popescu, President of the Board of Directors, Norofert.   The research and development of new products represents for the Company the main growth vector in the medium and long term, the strongest differentiator in a European market where the vast majority of manufacturers do not have a research department in the company. This laboratory has the capacity not only to produce raw materials needed for the factory but also to sell strains of microorganisms, in liquid or solid form, with technologies adapted to the requirements of local and international markets.